Skip to content

13F-HR filed by M28 Capital Management LP

M28 Capital Management LP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-13 21:59:44 UTC, with 9 holding rows worth $36,042,654.

Accession
0000902664-26-004537
Filed
2026-11-13
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 9 entries on the cover page, a total value of $36,042,654 stated on the cover page (in dollars after the unit check, H1), rows summing to $36,042,654 with VALUE read as dollars as filed, 13F file number 028-21846. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Wave Life Sciences Inc.94352A104COM4,588,284$16,976,651dollars as filed
INVIVYD INC00534A102COMMON STOCK9,248,250$8,046,902dollars as filed
TG THERAPEUTICS INC COM88322Q108Stock88,354$4,928,386dollars as filed
ARROWHEAD PHARMACEUTICALS IN04280A100COM36,851$2,411,898dollars as filed
SILENCE THERAPEUTICS PLC82686Q101ADS101,203$1,106,149dollars as filed
FRACTYL HEALTH INC35168W103COM1,856,117$1,010,470dollars as filed
PROQR THERAPEUTICS NVN71542109SHS EURO599,793$995,656dollars as filed
ROCKET PHARMACEUTICALS INC77313F106COM210,871$554,591dollars as filed
Curis Inc231269408COM14,244$11,951dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000902664-26-004537this filing2026-11-13